title: [Pharmacological and clinical profile of lansoprazole (Takepron IV injection 30 mg)].
authors.affiliation: Inatomi_Nobuhiro@takeda.co.jp
authors.forename: Nobuhiro
authors.initials: N
authors.lastname: Inatomi
authors.forename: Katsuyuki
authors.initials: K
authors.lastname: Nitta
authors.forename: Yuichi
authors.initials: Y
authors.lastname: Sakurai
mesh_terms: D053799:2-Pyridinylmethylsulfinylbenzimidazoles / Q000494:pharmacology* / Q000627:therapeutic use*; D000818:Animals; D000897:Anti-Ulcer Agents / Q000494:pharmacology* / Q000627:therapeutic use*; D005744:Gastric Acid / Q000502:physiology; D005753:Gastric Mucosa / Q000187:drug effects; D006471:Gastrointestinal Hemorrhage / Q000188:drug therapy; D006801:Humans; D064747:Lansoprazole; D010438:Peptic Ulcer Hemorrhage / Q000188:drug therapy
chemical_list: D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000897:Anti-Ulcer Agents; D064747:Lansoprazole